Neil Skolnik

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records
Address1025 Walnut St.
Philadelphia PA 19107
Phone215-481-2739
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Panettieri RA, Chipps B, Skolnik N, George M, Murphy K, Lugogo N. The use of albuterol/budesonide as reliever therapy to reduce asthma exacerbations. J Allergy Clin Immunol Pract. 2024 Feb 03. PMID: 38316182.
      Citations:    
    2. Skolnik N, Norden M, Lugogo N, Wright W. Use of ICS and Fast-Acting Bronchodilators in Asthma: Past, Present, and Future. J Fam Pract. 2023 07; 72(6 Suppl):S61-S70. PMID: 37549419.
      Citations:    
    3. Skolnik N. The American Academy of Pediatrics Obesity Guidelines-A Critical Appraisal. JAMA Pediatr. 2023 Jun 05. PMID: 37273218.
      Citations:    
    4. Tamondong-Lachica DR, Skolnik N, Hurst JR, Marchetti N, Rabe APJ, Montes de Oca M, Celli BR. GOLD 2023 Update: Implications for Clinical Practice. Int J Chron Obstruct Pulmon Dis. 2023; 18:745-754. PMID: 37180752.
      Citations:    
    5. Skolnik N. In Honor of the Pig. JAMA Cardiol. 2023 Apr 05. PMID: 37017944.
      Citations:    
    6. Mintz M, Barjaktarevic I, Mahler DA, Make B, Skolnik N, Yawn B, Zeyzus-Johns B, Hanania NA. Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review. Mayo Clin Proc. 2023 Feb; 98(2):301-315. PMID: 36737119.
      Citations:    
    7. Skolnik N, Style A. A Response to: Letter to the Editor regarding "Importance of Early Screening and Diagnosis of Chronic Kidney Disease in Patients with Type?2 Diabetes". Diabetes Ther. 2022 Sep; 13(9):1705-1706. PMID: 35930189.
      Citations:    
    8. Pace WD, Brandt E, Carter VA, Chang KL, Edwards CL, Evans A, Fox C, Gaona G, Han MK, Kaplan AG, Kent R, Kocks JWH, Kruszyk M, Le Lievre CE, Li Voti T, Mahle C, Make B, Ratigan AR, Shaikh A, Skolnik N, Stanley B, Yawn BP, Price DB. COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry. Ann Fam Med. 2022 Jul-Aug; 20(4):319-327. PMID: 35879087.
      Citations:    
    9. Lugogo N, Skolnik N, Jiang Y. A Paradigm Shift for Asthma Care. J Fam Pract. 2022 07; 71(6 Suppl):S1-S10. PMID: 35960943.
      Citations:    
    10. Fox C, Pace W, Brandt E, Carter V, Chang KL, Edwards C, Evans A, Gaona G, Han MK, Kaplan A, Kent R, Kocks JWH, Kruszyk M, Chantal LL, LiVoti T, Mahle C, Make B, Ratigan A, Shaikh A, Skolnik N, Stanley B, Yawn BP, Price DB. Variation in Demographic and Clinical Characteristics of Patients with COPD Receiving Care in US Primary Care: Data from the Advancing the Patient EXperience (APEX) in COPD Registry. Pragmat Obs Res. 2022; 13:17-31. PMID: 35516162.
      Citations:    
    11. Amaro A, Skolnik NS, Sugimoto D. Cardiometabolic risk factors efficacy of semaglutide in the STEP program. Postgrad Med. 2022 Jan; 134(sup1):18-27. PMID: 36691308.
      Citations:    
    12. Kyrillos JV, Skolnik NS, Mukhopadhyay B, Pennings N. Integrating semaglutide into obesity management - a primary care perspective. Postgrad Med. 2022 Jan; 134(sup1):37-49. PMID: 36691306.
      Citations:    
    13. Davies MJ, Rosenstock J, Ali A, Russell-Jones D, Souhami E, Palmer K, Ji C, Niemoeller E, Skolnik N. Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin =8%, =64?mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan-O randomized trial. Diabetes Obes Metab. 2022 01; 24(1):34-41. PMID: 34617398.
      Citations:    
    14. Pettus J, Skolnik N. Importance of diabetes management during the COVID-19 pandemic. Postgrad Med. 2021 Nov; 133(8):912-919. PMID: 34602003.
      Citations:    
    15. Lee JL, Foschini L, Kumar S, Juusola J, Liska J, Mercer M, Tai C, Buzzetti R, Clement M, Cos X, Ji L, Kanumilli N, Kerr D, Montanya E, M?ller-Wieland D, Ostenson CG, Skolnik N, Woo V, Burlet N, Greenberg M, Samson SI. Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial. NPJ Digit Med. 2021 Sep 17; 4(1):138. PMID: 34535755.
      Citations:    
    16. Skolnik NS, Style AJ. Importance of Early Screening and Diagnosis of Chronic Kidney Disease in Patients with Type 2 Diabetes. Diabetes Ther. 2021 Jun; 12(6):1613-1630. PMID: 33914300.
      Citations:    
    17. Skolnik N. Gratitude. Circulation. 2021 03 16; 143(11):1071-1072. PMID: 33720775.
      Citations:    
    18. Skolnik N, Del Prato S, Blonde L, Galstyan G, Rosenstock J. Translating iGlarLixi Evidence for the Management of Frequent Clinical Scenarios in Type 2 Diabetes. Adv Ther. 2021 04; 38(4):1715-1731. PMID: 33620694.
      Citations:    
    19. Edwards CL, Kaplan AG, Yawn BP, Kocks JWH, Bulathsinhala L, Carter VA, Chang KL, Fox C, Gopalan G, Han MK, Kruszyk M, Le Lievre CE, Mahle C, Make B, Pace WD, Price C, Shaikh A, Skolnik N, Price DB. Development of the Advancing the Patient Experience in COPD Registry: A Modified Delphi Study. Chronic Obstr Pulm Dis. 2021 Jan; 8(1). PMID: 33238085.
      Citations:    
    20. Yawn BP, Kaplan A, Pace WD, Kocks JWH, Bulathsinhala L, Carter VA, Chang KL, Edwards CL, Fox C, Gaona G, Gopalan G, Han MK, Kruszyk M, Le Lievre CE, Mahle CD, Make B, Philip ZK, Price C, Ratigan AR, Shaikh A, Skolnik N, Stanley B, Price DB. Advancing the Patient EXperience (APEX) in COPD Registry: Study Design and Strengths. J Am Board Fam Med. 2021 Jan-Feb; 34(1):22-31. PMID: 33452079.
      Citations:    
    21. Cloutier MM, Baptist AP, Blake KV, Brooks EG, Bryant-Stephens T, DiMango E, Dixon AE, Elward KS, Hartert T, Krishnan JA, Lemanske RF, Ouellette DR, Pace WD, Schatz M, Skolnik NS, Stout JW, Teach SJ, Umscheid CA, Walsh CG. 2020 Focused Updates to the Asthma Management Guidelines: A?Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020 12; 146(6):1217-1270. PMID: 33280709.
      Citations:    
    22. Peng XV, McCrimmon RJ, Shepherd L, Boss A, Lubwama R, Dex T, Skolnik N, Ji L, Avogaro A, Blonde L. Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study. Diabetes Ther. 2020 Nov; 11(11):2629-2645. PMID: 32902774.
      Citations:    
    23. Doyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo J. Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline. Ann Intern Med. 2020 11 17; 173(10):813-821. PMID: 32866414.
      Citations:    
    24. Morales J, Shubrook JH, Skolnik N. Practical guidance for use of oral semaglutide in primary care: a narrative review. Postgrad Med. 2020 Nov; 132(8):687-696. PMID: 32643514.
      Citations:    
    25. Sutton A, Skolnik N. COVID-19 CRISIS: we must care for ourselves as we care for others. J Fam Pract. 2020 04; 69(3):119;153. PMID: 32289124.
      Citations:    
    26. Hurst JR, Skolnik N, Hansen GJ, Anzueto A, Donaldson GC, Dransfield MT, Varghese P. Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life. Eur J Intern Med. 2020 03; 73:1-6. PMID: 31954592.
      Citations:    
    27. Skolnik NS, Nguyen TS, Shrestha A, Ray R, Corbridge TC, Brunton SA. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting ?2-agonist bronchodilators. Postgrad Med. 2020 Mar; 132(2):198-205. PMID: 31900019.
      Citations:    
    28. Umpierrez GE, Skolnik N, Dex T, Traylor L, Chao J, Shaefer C. When basal insulin is not enough: response to M Davidson. Diabetes Obes Metab. 2020 04; 22(4):711-712. PMID: 31724245.
      Citations:    
    29. Skolnik N. Treating Hypercholesterolemia in Older Adults-Reply. JAMA. 2019 08 20; 322(7):695-696. PMID: 31429894.
      Citations:    
    30. Chamberlain JJ, Doyle-Delgado K, Peterson L, Skolnik N. Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med. 2019 09 17; 171(6):415-420. PMID: 31404925.
      Citations:    
    31. Skolnik NS, Carnahan SP. Primary care of asthma: new options for severe eosinophilic asthma. Curr Med Res Opin. 2019 07; 35(7):1309-1318. PMID: 30880484.
      Citations:    
    32. Skolnik N. Reexamining Recommendations for Treatment of Hypercholesterolemia in Older Adults. JAMA. 2019 04 02; 321(13):1249-1250. PMID: 30855637.
      Citations:    
    33. Umpierrez GE, Skolnik N, Dex T, Traylor L, Chao J, Shaefer C. When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control. Diabetes Obes Metab. 2019 06; 21(6):1305-1310. PMID: 30724009.
      Citations:    
    34. Pablo Frias J, Lorenz M, Roberts M, Dex T, Schmider W, Hurst W, Skolnik N. Impact of lixisenatide dose range on clinical outcomes with fixed-ratio combination iGlarLixi in patients with type 2 diabetes. Curr Med Res Opin. 2019 04; 35(4):689-695. PMID: 30360647.
      Citations:    
    35. Handelsman Y, Chovanes C, Dex T, Giorgino F, Skolnik N, Souhami E, Stager W, Niemoeller E, Frias JP. Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes. J Diabetes Complications. 2019 03; 33(3):236-242. PMID: 30600136.
      Citations:    
    36. Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician. Adv Ther. 2018 11; 35(11):1763-1774. PMID: 30357570.
      Citations:    
    37. Aroda V, Johnson EL, Novak L, Skolnik N. Optimizing Insulin Therapy: Basal Insulin and Beyond. J Fam Pract. 2018 10; 67(10 Suppl). PMID: 30423012.
      Citations:    
    38. Skolnik N, Kaplan AG, Lake T, Hayden ML, Hanania NA. COPD Management in the Primary Care Setting. J Fam Pract. 2018 10; 67(10 Suppl):S27-S32. PMID: 30423008.
      Citations:    
    39. Blonde L, Dendy JA, Skolnik N, White JR. From Randomized Controlled Trials to the Real World: Putting Evidence into Context. J Fam Pract. 2018 08; 67(8 suppl):S55-S60. PMID: 30137055.
      Citations:    
    40. Skolnik N. Initial Treatment of Hypertension. N Engl J Med. 2018 05 17; 378(20):1953. PMID: 29770684.
      Citations:    
    41. Skolnik N, Hinnen D, Kiriakov Y, Magwire ML, White JR. Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know. Clin Diabetes. 2018 Apr; 36(2):174-182. PMID: 29686457.
      Citations:    
    42. Skolnik N. Icarus, Blood Pressure, and the Dangers of Flying Too Close to the Sun. Circulation. 2018 03 13; 137(11):1097-1099. PMID: 29530889.
      Citations:    
    43. Dhand R, Cavanaugh T, Skolnik N. Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease. Cleve Clin J Med. 2018 Feb; 85(2 Suppl 1):S19-S27. PMID: 29494329.
      Citations:    
    44. Skolnik N. Inconsistent Hypertension Guidelines: We Need a Little Help Here. JAMA Intern Med. 2018 02 01; 178(2):297-298. PMID: 29404613.
      Citations:    
    45. Dhand R, Cavanaugh T, Skolnik N. COPD in Primary Care: Key Considerations for Optimized Management: Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease. J Fam Pract. 2018 02; 67(2 Suppl):S19-S27. PMID: 29443333.
      Citations:    
    46. Gupta S, Wang H, Skolnik N, Tong L, Liebert RM, Lee LK, Stella P, Cali A, Preblick R. Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study. Adv Ther. 2018 01; 35(1):43-55. PMID: 29313285.
      Citations:    
    47. Cersosimo E, Johnson EL, Chovanes C, Skolnik N. Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approach. Diabetes Obes Metab. 2018 03; 20(3):497-507. PMID: 28862799.
      Citations:    
    48. Chamberlain JJ, Kalyani RR, Leal S, Rhinehart AS, Shubrook JH, Skolnik N, Herman WH. Treatment of Type 1 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med. 2017 Oct 03; 167(7):493-498. PMID: 28892816.
      Citations:    
    49. Skolnik N. No Wonder No One Trusts Us. JAMA Intern Med. 2017 09 01; 177(9):1253. PMID: 28738132.
      Citations:    
    50. Umpierrez GE, Bailey TS, Carcia D, Shaefer C, Shubrook JH, Skolnik N. Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies. J Diabetes. 2018 Feb; 10(2):94-111. PMID: 28581207.
      Citations:    
    51. Skolnik N, Dupree RS, Johnson EL. iGlarLixi, a titratable once-daily fixed-ratio combination of basal insulin and lixisenatide for intensifying type 2 diabetes management for patients inadequately controlled on basal insulin with or without oral agents. Curr Med Res Opin. 2017 12; 33(12):2187-2194. PMID: 28741967.
      Citations:    
    52. Skolnik N. The Best We Can Be. Circulation. 2017 07 18; 136(3):247-248. PMID: 28716829.
      Citations:    
    53. Skolnik N, Jaffa FM, Kalyani RR, Johnson E, Shubrook JH. Reducing CV risk in diabetes: An ADA update. J Fam Pract. 2017 May; 66(5):300-308. PMID: 28459890.
      Citations:    
    54. Skolnik NS, Jaffa F, Kiriakov Y. Hot Topics in Primary Care: Individualizing Dual Therapy for Type 2 Diabetes Mellitus. J Fam Pract. 2017 Apr; 66(4 Suppl):S4-S9. PMID: 28375401.
      Citations:    
    55. Chamberlain JJ, Herman WH, Leal S, Rhinehart AS, Shubrook JH, Skolnik N, Kalyani RR. Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med. 2017 Apr 18; 166(8):572-578. PMID: 28288484.
      Citations:    
    56. Skolnik N. Letter from Skolnik Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial". Circulation. 2016 Sep 06; 134(10):e187-8. PMID: 27601564.
      Citations:    
    57. Skolnik N. Tithonus Syndrome. JAMA Intern Med. 2016 09 01; 176(9):1247. PMID: 27398872.
      Citations:    
    58. Skolnik NS, Horn DB. Answers to Clinical Questions in the Primary Care Management of People with Obesity: Lifestyle Management. J Fam Pract. 2016 07; 65(7 Suppl):S13-6. PMID: 27565105.
      Citations:    
    59. Johnson E, Warren F, Skolnik N, Shubrook JH. Diabetes update: Your guide to the latest ADA standards. J Fam Pract. 2016 05; 65(5):310-8. PMID: 27275934.
      Citations:    
    60. Skolnik N, Bonnes H, Yeh H, Katz A. Dapagliflozin in the treatment of patients with type 2 diabetes presenting with high baseline A1C. Postgrad Med. 2016 May; 128(4):356-63. PMID: 27043045.
      Citations:    
    61. Skolnik N, Grover A. Diabetes Has Gotten Pretty Darn Complicated. Clin Diabetes. 2015 Jul; 33(3):114-5. PMID: 26203203.
      Citations:    
    62. Skolnik NS, Ryan DH. Pathophysiology, epidemiology, and assessment of obesity in adults. J Fam Pract. 2014 Jul; 63(7 Suppl):S3-S10. PMID: 25198218.
      Citations:    
    63. Skolnik N. Don't restrict funding from drug companies for doctors' education. BMJ. 2013 Nov 08; 347:f6452. PMID: 24212106.
      Citations:    
    64. Skolnik N. Guidelines for glycemic control and individualized targets. JAMA. 2010 Sep 08; 304(10):1069; author reply 1069-70. PMID: 20823431.
      Citations:    
    65. Skolnik N. Amiodarone for atrial fibrillation. N Engl J Med. 2007 Jun 07; 356(23):2424-6; author reply 2424-6. PMID: 17561532.
      Citations:    
    66. Skolnik NS, Beck JD, Clark M. Combination antihypertensive drugs: recommendations for use. Am Fam Physician. 2000 May 15; 61(10):3049-56. PMID: 10839554.
      Citations:    
    67. Skolnik NS. Screening for Chlamydia trachomatis infection. Am Fam Physician. 1995 Mar; 51(4):821-6. PMID: 7887358.
      Citations:    
    68. Skolnik NS, Smith DR, Diamond J. Professional satisfaction and dissatisfaction of family physicians. J Fam Pract. 1993 Sep; 37(3):257-63. PMID: 8409877.
      Citations:    
    69. Skolnik N. Croup. J Fam Pract. 1993 Aug; 37(2):165-70. PMID: 8336098.
      Citations:    
    70. Skolnik NS. Treatment of croup. A critical review. Am J Dis Child. 1989 Sep; 143(9):1045-9. PMID: 2672782.
      Citations:    
    71. Skolnik NS. On the importance of retaining a feeling of sensitivity and wonder during years of intensive medical training. Am J Med. 1988 Mar; 84(3 Pt 1):511-2. PMID: 3348250.
      Citations:    
    Skolnik's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (213)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _